Dopaminergic Modulation of Local Non-oscillatory Activity and Global-Network Properties in Parkinson’s Disease: An EEG Study.

Authors
Zhang J, Villringer A, Nikulin VV.
Journal
Front Aging Neurosci.

Abstract

Dopaminergic medication for Parkinson’s disease (PD) modulates neuronal oscillations and functional connectivity (FC) across the basal ganglia-thalamic-cortical circuit. However, the non-oscillatory component of the neuronal activity, potentially indicating a state of excitation/inhibition balance, has not yet been investigated and previous studies have shown inconsistent changes of cortico-cortical connectivity as a response to dopaminergic medication. To further elucidate changes of regional non-oscillatory component of the neuronal power spectra, FC, and to determine which aspects of network organization obtained with graph theory respond to dopaminergic medication, we analyzed a resting-state electroencephalography (EEG) dataset including 15 PD patients during OFF and ON medication conditions. We found that the spectral slope, typically used to quantify the broadband non-oscillatory component of power spectra, steepened particularly in the left central region in the ON compared to OFF condition. In addition, using lagged coherence as a FC measure, we found that the FC in the beta frequency range between centro-parietal and frontal regions was enhanced in the ON compared to the OFF condition. After applying graph theory analysis, we observed that at the lower level of topology the node degree was increased, particularly in the centro-parietal area. Yet, results showed no significant difference in global topological organization between the two conditions: either in global efficiency or clustering coefficient for measuring global and local integration, respectively. Interestingly, we found a close association between local/global spectral slope and functional network global efficiency in the OFF condition, suggesting a crucial role of local non-oscillatory dynamics in forming the functional global integration which characterizes PD. These results provide further evidence and a more complete picture for the engagement of multiple cortical regions at various levels in response to dopaminergic medication in PD.

Published: Apr 2022
Share

https://sfb-retune.de/wp-content/uploads/2021/11/logo-charite.png
https://sfb-retune.de/wp-content/uploads/2021/11/logo-ukw.png
https://sfb-retune.de/wp-content/uploads/2021/11/logo-uni-duesseldorf.png
https://sfb-retune.de/wp-content/uploads/2021/11/logo-ltr.png
https://sfb-retune.de/wp-content/uploads/2021/11/logo-mpi.png
https://sfb-retune.de/wp-content/uploads/2021/11/logo-uni-potsdam.png
https://sfb-retune.de/wp-content/uploads/2021/11/logo-uni-rostock.png
https://sfb-retune.de/wp-content/uploads/2021/11/logo-uni-wuerzburg.png
https://sfb-retune.de/wp-content/uploads/2021/11/logo-bernstein.png